IDenta Corp.
IDTA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.42M
Close$
$0.13
64.2% downside
Current Fair Value
64.2% downsideOvervalued by 64.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.42 Million |
|---|---|
| Enterprise Value | $1.41 Million |
| Earnings per Share | $0.02 |
| Beta | 0.62 |
| Outstanding Shares | 4,314,270 |
Return
| Return on Equity | 10.84% |
|---|---|
| Return on Assets | 5.93% |
| Return on Invested Capital | 12.34% |
Valuation & Multiples
| P/E Ratio | 9.83 |
|---|---|
| PEG | -0.54 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | 5.98 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.47 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About IDenta Corp.
14 employees
CEO: Amichai Glattstein
IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solut...